The report offered the following description: At present there are four crematoria in operation at BIRKENAU, two large ones, I and II, and two smaller ones, III and IV.
In view of the Hypotheses 2.1(i) and (iv), one can show that the same is true for the processes ((V^{i})) and ((widetilde{V}^{i})) by using the following argument.
After electrophoresis, to evaluate the amount of respiratory chain complexes I and IV, one gel was fixed in 40% methanol and stained overnight with a Coomassie Blue Solution (Brillant Blue G and methanol used at a ratio of 1 : 4, respectively).
Interestingly, the relationship between copeptin and the primary end point was stronger among incident diabetic individuals than among prevalent ones (Tables III and IV).
We classified genes as being maternal or zygotic through another microarray experiment utilizing mRNA pre- and post-MBT; those showing a decrease of mRNA levels from pre- to post-MBT (MBT down) were classified as prevalently maternal and vice versa (MBT up) for prevalently zygotic ones (Supplementary Tables III and IV).
Case-mix adjusted estimates of practice level scores were calculated for items addressing four components of patient experience: i) communication with doctors and nurses (four questions); ii) access to care (three questions); iii) continuity of care (one question); and iv) overall satisfaction with care (one question).
Dose-limiting toxicities were hyperglycaemia with hyperosmolar coma at 3 mg m−2, and (i) one anasarque and haematemesis, (ii) one life-threatening pulmonary aspergillosis, (iii) one skin rash and (iv) one scalp pain at dose level of 5 mg m−2 day−1.
Five DLTs were observed, one grade 3 hyperglycaemia with hyperosmolar coma at 3 mg m−2 requiring insulin and rehydration, and four DLTs at dose level of 5 mg m−2 day−1: (i) one anasarque and haematemesis, (ii) one life-threatening pulmonary aspergillosis, (iii) one skin rash and (iv) one scalp pain.
'Atypical' non-heme-Fe(II) binding sites coordinate the metal center by (i) two histidine-, (ii) three histidine-, (iii) three histidine- and one carboxylate- and (iv) four histidine-side chains.
In addition to the summary statistics characteristic of all barriers, reference composite barriers are described by a particular combination of individual barriers with four criteria: (i) number of barriers, (ii) total area, (iii) geographic proximity to one another, and (iv) the same inflection.
The set of clones chosen for BAC-FISH contained: (i) all 11 clones carrying gene-like sequences in their BESs, (ii) 10 clones with no significant identity to any gene or repetitive sequence in both BESs, (iii) 11 clones carrying repetitive elements in one BES, and (iv) five clones containing repetitive elements in both BESs.
